Difference between revisions of "Team:Hong Kong-CUHK/methods"
Line 33: | Line 33: | ||
<p><font face="Times New Roman" size="4pt">From research papers, we found that there are different operons that are used to produce and regulate the magnetosome formation. And among them, it is the mamAB operon that is the crucial operon that is needed for the production of magnetosome. Other operons like mamGFDC, mamXY, mms6 et cetera are more frequently used for regulating the size and shape and the biominerlization that facilitate the formation of magnetosome[1]. </p> | <p><font face="Times New Roman" size="4pt">From research papers, we found that there are different operons that are used to produce and regulate the magnetosome formation. And among them, it is the mamAB operon that is the crucial operon that is needed for the production of magnetosome. Other operons like mamGFDC, mamXY, mms6 et cetera are more frequently used for regulating the size and shape and the biominerlization that facilitate the formation of magnetosome[1]. </p> | ||
− | <p><font face="Times New Roman" size="4pt">Therefore, in our project this year, we would only insert the mamAB operon from MSG to our bacteria Azotobacter Vinelandii, hoping to test on using minimal number of genes to produce functional magnetosome. This aims at assisting the magnetosome formation progress making it easier to form for future research developments. </p></font> | + | <p><font face="Times New Roman" size="4pt">Therefore, in our project this year, we would only insert the mamAB operon from MSG to our bacteria <i>Azotobacter Vinelandii</i>, hoping to test on using minimal number of genes to produce functional magnetosome. This aims at assisting the magnetosome formation progress making it easier to form for future research developments. </p></font> |
<div class="photoLeft"> | <div class="photoLeft"> | ||
Line 41: | Line 41: | ||
<p><font face="Times New Roman" size="4pt">As it is shown in the diagram, the mamAB operon is a rather large operon consisting of 16.4 KB. Therefore it means the normal cloning strategy, by putting the gene of interest into a vector and transforming it into the targeted bacteria will have a lower successive rate.</p></font> | <p><font face="Times New Roman" size="4pt">As it is shown in the diagram, the mamAB operon is a rather large operon consisting of 16.4 KB. Therefore it means the normal cloning strategy, by putting the gene of interest into a vector and transforming it into the targeted bacteria will have a lower successive rate.</p></font> | ||
− | <p><font face="Times New Roman" size="4pt">Therefore, a new method was required to help the transfer of such a large operon into the Azotobacter vinelandii. Our new method involves the <b>making of a template vector first, follow by homologous recombination and then random integration (Figure 3). </b></p></font> | + | <p><font face="Times New Roman" size="4pt">Therefore, a new method was required to help the transfer of such a large operon into the <i>Azotobacter vinelandii</i>. Our new method involves the <b>making of a template vector first, follow by homologous recombination and then random integration (Figure 3). </b></p></font> |
<div class="photoright"> | <div class="photoright"> | ||
Line 48: | Line 48: | ||
</div> | </div> | ||
− | <p><font face="Times New Roman" size="4pt">Furthermore, as the mamAB operon is too long for normal insertion, we have decided to firstly split it into two. Once all recombination and integrations are done, the split mamAB operon should be recombined again inside the azotobacter genome. </p></font> | + | <p><font face="Times New Roman" size="4pt">Furthermore, as the mamAB operon is too long for normal insertion, we have decided to firstly split it into two. Once all recombination and integrations are done, the split mamAB operon should be recombined again inside the <i>azotobacter genome</i>. </p></font> |
<p><font face="Times New Roman" size="4pt">The start of the mamAB operon is the mamH gene with the ending gene being mamU. The mamAB operon will be cut at around half way of the operon. And the cutting point is between the mamN and mamO genes. In consequence, the first half of mamAB will be starting with mamH, ending with mamN; and the second half will be starting from mamO, ending with mamU. </p></font> | <p><font face="Times New Roman" size="4pt">The start of the mamAB operon is the mamH gene with the ending gene being mamU. The mamAB operon will be cut at around half way of the operon. And the cutting point is between the mamN and mamO genes. In consequence, the first half of mamAB will be starting with mamH, ending with mamN; and the second half will be starting from mamO, ending with mamU. </p></font> | ||
− | <p><font face="Times New Roman" size="4pt">Hence, in order to put our gene of interest (mamAB operon) into a vector, we need to produce a template first and put it into E .coli (the strand of E. coli we are using is BL21). The template which we used is a vector which includes J13002 (consists of the constitutive promoter R0040 and the RBS); the flanking sequences; and the double terminator. All in between the multiple restriction sites. </p></font> | + | <p><font face="Times New Roman" size="4pt">Hence, in order to put our gene of interest (mamAB operon) into a vector, we need to produce a template first and put it into <i>E .coli</i> (the strand of <i>E. coli</i> we are using is BL21). The template which we used is a vector which includes J13002 (consists of the constitutive promoter R0040 and the RBS); the flanking sequences; and the double terminator. All in between the multiple restriction sites. </p></font> |
− | <p><font face="Times New Roman" size="4pt">Flanking sequences are actually the first 250 bp and also last 250 bp of the whole linkage of genes which we want to “flip into” our template. Therefore in order to flip in the first half of the mamAB operon, in other words, the one starting with mamH and ends with mamN, we need to have a total of two flanking sequences. This is done by making the first 250bp of mamH as the first flanking sequence and also the last 250 bp of mamN as the second flanking sequence in the template. As BL21 (the strand of E. coli) has a special enzyme RecA, therefore it is able to perform in vivo homologous recombination[2].</p></font> | + | <p><font face="Times New Roman" size="4pt">Flanking sequences are actually the first 250 bp and also last 250 bp of the whole linkage of genes which we want to “flip into” our template. Therefore in order to flip in the first half of the mamAB operon, in other words, the one starting with mamH and ends with mamN, we need to have a total of two flanking sequences. This is done by making the first 250bp of mamH as the first flanking sequence and also the last 250 bp of mamN as the second flanking sequence in the template. As BL21 (the strand of <i>E. coli</i>) has a special enzyme RecA, therefore it is able to perform in vivo homologous recombination[2].</p></font> |
<p><font face="Times New Roman" size="4pt">With these homologous parts as our template, we can then flip in both parts of the mamAB operon into the vector which should be much easier than ligating such a long mamAB operon into the vector by usual method. As vectors by usual method usually can’t uphold more than 10kb gene of interest. </p></font> | <p><font face="Times New Roman" size="4pt">With these homologous parts as our template, we can then flip in both parts of the mamAB operon into the vector which should be much easier than ligating such a long mamAB operon into the vector by usual method. As vectors by usual method usually can’t uphold more than 10kb gene of interest. </p></font> | ||
Line 64: | Line 64: | ||
<p><font face="Times New Roman" size="4pt">Furthermore, by cutting one restriction site, the plasmid containing the whole mamAB operon with its promoter, RBS and double terminator and an antibiotic resistant gene will be linearized for random genome integration afterwards. </p> | <p><font face="Times New Roman" size="4pt">Furthermore, by cutting one restriction site, the plasmid containing the whole mamAB operon with its promoter, RBS and double terminator and an antibiotic resistant gene will be linearized for random genome integration afterwards. </p> | ||
− | <p><font face="Times New Roman" size="4pt">The linear fragment will then be feed into the Azotobacter vinelandii by the method called random integration. In other words, the linear DNA will just go inside the Azotobacter and be randomly integrated into its genomic DNA which is a “self-property” of the Azotobacter vinelandii. </p></font> | + | <p><font face="Times New Roman" size="4pt">The linear fragment will then be feed into the <i>Azotobacter vinelandii</i> by the method called random integration. In other words, the linear DNA will just go inside the <i>Azotobacter</i> and be randomly integrated into its genomic DNA which is a “self-property” of the <i>Azotobacter vinelandii</i>. </p></font> |
<p>(Gel photo to be added) </p> | <p>(Gel photo to be added) </p> | ||
Line 97: | Line 97: | ||
<p> | <p> | ||
− | 1. LOHßE, Anna, et al. Genetic dissection of the mamAB and mms6 operons reveals a gene set essential for magnetosome biogenesis in Magnetospirillum gryphiswaldense. Journal of bacteriology, 2014, 196.14: 2658-2669. | + | 1. LOHßE, Anna, et al. Genetic dissection of the mamAB and mms6 operons reveals a gene set essential for magnetosome biogenesis in <i>Magnetospirillum gryphiswaldense</i>. <i>Journal of bacteriology</i>, 2014, 196.14: 2658-2669. |
</p> | </p> | ||
<p> | <p> | ||
− | 2. CHEN, Zhucheng; YANG, Haijuan; PAVLETICH, Nikola P. Mechanism of homologous recombination from the RecA–ssDNA/dsDNA structures. Nature, 2008, 453.7194: 489-494. | + | 2. CHEN, Zhucheng; YANG, Haijuan; PAVLETICH, Nikola P. Mechanism of homologous recombination from the RecA–ssDNA/dsDNA structures. <i>Nature</i>, 2008, 453.7194: 489-494. |
</p> | </p> | ||
<p> | <p> | ||
− | 3. XU, Jun, et al. Surface expression of protein A on magnetosomes and capture of pathogenic bacteria by magnetosome/antibody complexes. Frontiers in microbiology, 2014, 5. | + | 3. XU, Jun, et al. Surface expression of protein A on magnetosomes and capture of pathogenic bacteria by magnetosome/antibody complexes. <i>Frontiers in microbiology</i>, 2014, 5. |
</p> | </p> | ||
</div></center> | </div></center> | ||
</html> | </html> |
Revision as of 17:10, 18 September 2015